Novocol Pharmaceutical of Canada, Inc. recalls darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in…
- Recall date
- October 31, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0231-2026
- FDA classification
- Class II
- Brand / firm
- Novocol Pharmaceutical of Canada, Inc.
- Sold / distributed
- U.S.A. Nationwide
Why it was recalled
Defective container: cracked/broken cartridges
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.
Get recall alerts
Free email alert whenever Novocol Pharmaceutical of Canada, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novocol Pharmaceutical of Canada, Inc.